scorecardresearch
Wednesday, August 27, 2025
TopicOxford University

Topic: Oxford University

Health partnership with India goes ‘beyond’ vaccines, says UK envoy Philip Barton

British High Commissioner to India Philip Barton said the Oxford vaccine will be manufactured in India & that really ‘illustrates our partnership in the health sector’.

Chances of Covid vaccine by this year is ‘very low’, says Boris Johnson’s medical adviser

The assessment came despite the Oxford vaccine effort showing promising results in early human testing and is a sign of ongoing uncertainty over the likelihood of quick success.

Oxford-AstraZeneca, Pfizer-BioNtech & Moderna — how the 3 potential Covid vaccines stack up

Results from phase 1 of the Oxford-AstraZeneca trial were promising, but analysts remain concerned about whether it can match its competitors Pfizer-BioNtech & Moderna.

What are human challenge trials — the experiment Oxford is considering for its Covid vaccine

Oxford vaccine is under Phase II/III trials in multiple countries, where many have been given the vaccine & are being followed up with — a process that consumes time, but is standard. 

India saw world’s largest reduction in poverty from 2005-16, says Oxford-UN study

Around 273 million people were lifted out of multidimensional poverty in India, the study by Oxford Poverty & Human Development Initiative with United Nations Development Programme has noted.

Clinical trials for Covid vaccine, developed by Oxford University, begin in South Africa

Heatwave risks during pandemic and cardiac problems in ICU patients, ThePrint brings you the latest research on coronavirus.

Not sure if HCQ works but adverse effects don’t seem to be a problem, say Indian doctors

The anti-malarial drug HCQ was left out of the WHO Solidarity trial and the USFDA emergency use list this week. Doctors in India say they don’t see any major side-effects from its use.

What is dexamethasone? The anti-inflammatory steroid being touted as new Covid treatment hope

Dexamethasone is the first drug to be shown to improve survival in Covid patients. It reduced deaths by one-third in ventilated patients, an Oxford study stated.

Low-cost steroid dexamethasone becomes first drug to improve Covid patients’ survival

Deaths among patients who needed assistance breathing were lower over a period of 4 weeks when they received dexamethasone, Oxford researchers said.

HCQ doesn’t reduce risk of death among hospitalised Covid patients, says Oxford study

About 26% of patients in the trial getting the drug died, compared with about 24% receiving standard care, according to the University of Oxford.

On Camera

Severe Hyderabad internet outages make it an IT hub without the IT part

Many offices in Telangana have asked their employees to work from home because of heavy rainfall, but it has become impossible due to the internet outages.

‘Not just Russian oil, India tapped us along on trade deal,’ says US treasury secy Scott Bessent

New Delhi: The US is not worried about the rupee “becoming a reserve currency” given that it is at an all-time low versus the...

CDS on differences on theaterisation—views welcome, final call to be in nation’s best interests

The Navy has always been on board with the theaterisation plan, but the Air Force feels splitting up air assets into several theatre commands is futile & will tie up critical systems.

That Oval Office picture for ages deserves closer Indian reading, with a geopolitical lens

Putin sees this as a victory. Europeans have decided to deal with Trump on his terms for the sake of the larger Western alliance. We look at the lessons for us in India.